DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Johnson & Johnson (NYSE: JNJ)



company name or ticker
Company Photos
(Click to zoom)

FDA’s New Warning About Invokana May Not Matter Much For J&J, Let’s Focus On Pipeline Instead

3 Ways To Diversify With Top Dividend ETFs

FDA approves longer-acting version of J&J's schizophrenia drug

The 4 Stocks That Lifted the DJIA on Monday

Apple Inc. Wants Your DNA, but Why?

The most valuable company on Earth is getting serious about DNA sequencing -- and it’s a perfect match.

Celgene's Crohn's Disease Drug Prompts Lingering Questions

Dow Movers: CVX, GS

J&J's Janssen Reports Data Demonstrates Adults with Type 2 Diabetes Achieved Blood Glucose Treatment

J&J's Janssen Reports Data Demonstrates Adults with Type 2 Diabetes Achieved Blood Glucose Treatment Goals with Use of INVOKANA

Making Dividend Champions Buyable Despite Inflated Valuations

UPS, CSCO, IBM, CI: Jim Cramer's Views

See More Articles...